Status:
COMPLETED
Salivary Biomarkers for Sjögren's Syndrome Detection
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Oklahoma Medical Research Foundation
University Medical Center Groningen
Conditions:
Sjögren's Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center clinical study to compare the performance of a collective panel of salivary biomarkers to discriminate SS from non-SS in sicca cohorts recruited from three clinical sites with t...
Detailed Description
Aim 1: Test the association using Odds Ratios between seven individual biomarkers (cathepsin D, α-enolase and β-2-microglobulin \[B2M\], anti-SSA, anti-SSB, anti-histone, anti-transglutaminase) with p...
Eligibility Criteria
Inclusion
- Ability to give informed consent (Appendix 1).
- Male or female patients 18 years of age or older.
- Patients with sicca symptoms as defined in Appendix 2.
- Must be willing to have a standard physical exam as part of standard clinical care and a complete diagnostic work-up according to the new ACR criteria for ocular staining, labial salivary gland biopsy and serology.
- Must be willing to have a standard physical exam and complete AECG diagnostic tests as part of standard clinical care (including eye exam, oral exam, salivary gland exam and biopsy).
- Must be willing to complete a questionnaire (approximately 10 min).
- Must be willing to donate 1ml of stimulated, whole saliva in 30 minutes or less. If a participant cannot produce 1ml during a 30 min collection period, subject will be unevaluable and will be considered a screen failure and withdrawn from the study.
- For UMCG only, subject must be willing to have a labial salivary gland biopsy in addition to a parotid biopsy.
- Must be willing and able to give approximately 8ml of blood.
- Must be willing to be tested for Hepatitis C, if required
Exclusion
- Previous radiation to the head and neck.
- Confirmed hepatitis C virus infection, which may cause SS-like signs and symptoms.
- Known HIV infection, which can cause salivary gland infiltrates and enlargements similar to SS.
- Sarcoidosis, which may cause SS-like signs and symptoms.
- Graft-versus-host disease, which may cause SS-like signs and symptoms.
- Oral cancer or history of oral cancer.
- Pregnancy based on self-report.
- Previously diagnosed with pSS or sSS using AECG criteria or SS using ACR criteria.
- Previously confirmed diagnosis of autoimmune disease known to be associated with Secondary Sjögren's syndrome (sSS) (rheumatoid arthritis (RA), systemic lupus erythematosus (SLE)), CREST (Calcinosis, Raynaud's syndrome, Esophageal dysmotility, Sclerodactyly, Telangiectasia), Scleroderma, Mixed connective tissue disease, Polymyositis.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT01807689
Start Date
April 1 2013
End Date
September 1 2018
Last Update
April 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA - School of Dentistry
Los Angeles, California, United States, 90095